Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2

BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) has been shown to exert a synergistic antitumor effect when combined with fluoropyrimidine. This synergy may be attributable to the downregulation of thymidylate synthase (TS), which is frequently overexpressed in fluo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hwang-Phill, Yoon, Young-Kwang, Kim, Jin-Won, Han, Sae-Won, Hur, Hyung-Seok, Park, Jinah, Lee, Ju-Hee, Oh, Do-Youn, Im, Seock-Ah, Bang, Yung-Jue, Kim, Tae-You
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691960/
https://www.ncbi.nlm.nih.gov/pubmed/19529774
http://dx.doi.org/10.1371/journal.pone.0005933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691960/
https://www.ncbi.nlm.nih.gov/pubmed/19529774
http://dx.doi.org/10.1371/journal.pone.0005933

Ejemplares similares